LEADERS FREE II: BioFreedom™ Pivotal Study

NCT02843633 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

1203

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome
High Bleeding Risk

Interventions

DEVICE: BioFreedom™ Drug Coated Coronary Stent System
DRUG: Antiplatelet Drug

Sponsor

Biosensors Europe SA